To the best of our knowledge, the present study was the first to demonstrate that the anticancer role of GSTM5 in bladder cancer and that the decreased levels of GSH play an important mediator of this function (Figure 9). This evidence concerns the gene GSTM5 and urinary bladder carcinoma.